Home › Vision Impairment and Blindness › Pennsylvania
Vision Impairment and Blindness clinical trials in Pennsylvania
3 studies for Vision Impairment and Blindness are looking for participants at sites in Pennsylvania.
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
- Retina-Vitreous Consultants, Inc., Monroeville
- Wills Eye Hospital, Philadelphia
- Pittsburgh Clinical Trial Consortium, Sewickley
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT05844982Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
- University of Pennsylvania - Center for Advanced Retinal & Ocular Therapeutics, Philadelphia
RecruitingPhase 3
Ages 6 and older · All sexes · Updated Oct 21, 2026 · NCT06891443OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
- Scott & Christie EyeCare Associates, Cranberry Township
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07140783From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.